Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MEDICAL ASSOCIATION OF NORTHEAST LOUISIANA INC.

NPI: 1023185220 · WEST MONROE, LA 71291 · Medical Specialty Clinic/Center · NPI assigned 11/30/2006

$747K
Total Medicaid Paid
48,237
Total Claims
38,224
Beneficiaries
39
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMOUHAFFEL, ASSAD (OWNER)
NPI Enumeration Date11/30/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,318 $138K
2019 5,949 $124K
2020 4,990 $110K
2021 5,847 $116K
2022 10,753 $111K
2023 9,002 $86K
2024 5,378 $62K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 6,579 5,726 $241K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 7,175 6,089 $131K
99232 Subsequent hospital care, per day, moderate complexity 4,947 2,448 $81K
99233 Prolong inpt eval add15 m 1,624 1,287 $81K
93458 795 691 $67K
93000 7,354 6,184 $33K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 644 542 $30K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 647 539 $29K
93015 727 613 $14K
99222 Initial hospital care, per day, moderate complexity 1,863 1,696 $12K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 303 245 $9K
99231 Subsequent hospital care, per day, straightforward or low complexity 1,050 515 $8K
93016 564 506 $5K
93018 564 506 $3K
99221 132 121 $958.76
93356 87 62 $555.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20 17 $503.75
J1245 Injection, dipyridamole, per 10 mg 240 213 $399.81
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) 14 13 $259.09
99443 241 125 $124.41
G0278 Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure) 18 16 $50.40
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 12 12 $11.34
G8753 Most recent systolic blood pressure >= 140 mmhg 407 330 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 2,304 1,835 $0.00
G8752 Most recent systolic blood pressure < 140 mmhg 592 467 $0.00
G8935 Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy 790 617 $0.00
G8937 Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given 199 157 $0.00
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 42 31 $0.00
G9664 Patients who are currently statin therapy users or received an order (prescription) for statin therapy 756 595 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 1,829 1,446 $0.00
G2197 Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user 2,164 1,732 $0.00
G8754 Most recent diastolic blood pressure < 90 mmhg 715 570 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 143 120 $0.00
4086F 1,713 1,371 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 196 155 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 271 218 $0.00
G9662 Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure 471 371 $0.00
G8936 Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) 31 30 $0.00
J0280 Injection, aminophyllin, up to 250 mg 14 13 $0.00